Effect of N-acetylcysteine on carboplatin-induced ototoxicity and nitric oxide levels in a rat model

Laryngoscope

Volumn 117, Issue 12, 2007, Pages 2183-2186

  Okur, Erdogan ^a   Kilinc, Metin ^a   Yildirim, Ilhami ^a   Kilic, M Akif ^a   Tolun, Fatma Inanc ^a  

^a KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

Author keywords

Carboplatin; Distortion product otoacoustic emissions; Glutathione peroxidase; Nitric oxide; Ototoxicity; Rat

Indexed keywords

ACETYLCYSTEINE; CARBOPLATIN; GLUTATHIONE PEROXIDASE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COCHLEA; CONTROLLED STUDY; DISTORTION PRODUCT OTOACOUSTIC EMISSION; DRUG EFFECT; DRUG MECHANISM; HEARING LOSS; MALE; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; RAT;

ACETYLCYSTEINE; ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; CARBOPLATIN; COCHLEA; DISEASE MODELS, ANIMAL; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FOLLOW-UP STUDIES; FREE RADICAL SCAVENGERS; GLUTATHIONE PEROXIDASE; HEARING LOSS, SENSORINEURAL; MALE; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; SPECTROPHOTOMETRY; TREATMENT OUTCOME;

EID: 40349096523     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLG.0b013e31813e6041     Document Type: Article

References (21)

1. Harland SJ, Newell DR, Siddik ZH, Chadwick R, Calvert AH, Harrap KR. Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum (II) in patients with normal and impaired renal function. Cancer Res 1984;44:1693-1697.
2. Ruckdeschel JC. The future role of carboplatin. Semin Oncol 1994;21:114-118.
3. De Lauretis A, De Capua B, Barbieri MT, Bellussi L, Passali D. ABR evaluation of ototoxicity in cancer patients receiving cisplatin or carboplatin. Scand Audiol 1999;28:139-143.
4. Cavaletti G, Bogliun G, Zincone A, et al. Neuro- and ototoxicity of high-dose carboplatin treatment in poor prognosis ovarian cancer patients. Anticancer Res 1998;18:3797-3802.
5. Kennedy IC, Fitzharris BM, Colls BM, Atkinson CH. Carboplatin is ototoxic. Cancer Chemother Pharmacol 1990;26:232-234.
6. Husain K, Whitworth C, Somani SM, Rybak LP. Carboplatin-induced oxidative stress in rat cochlea. Hear Res 2001;159:14-22.
7. Neuwelt EA, Pagel MA, Hasler BP, Deloughery TG, Muldoon LL. Therapeutic efficacy of aortic administration of N-acetylcysteine as a chemoprotectant against bone marrow toxicity after intracarotid administration of alkylators, with or without glutathione depletion in a rat model. Cancer Res 2001;61:7868-7874.
8. Feghali JG, Liu W, Van De Water TR. L-n-acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity. Laryngoscope 2001;111:1147-1155.
9. Watanabe K, Hess A, Bloch W, Michel O. Expression of inducible nitric oxide synthase (iNOS/NOS II) in the vestibule of guinea pigs after the application of cisplatin. Anticancer Drugs 2000;11:29-32.
10. Hatzopoulos S, Petruccelli J, Laurell G, Previati M, Martini A. Electrophysiological findings in the Sprague-Dawley rat induced by moderate-dose carboplatin. Hear Res 2003;182:48-55.
11. Cortas NK, Wakid NW. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 1990;36:1440-1443.
12. Beutler E. Red Cell Metabolism,ed 2. New York: Grune and Starton; 1975.
13. Lockwood DS, Ding DL, Wang J, Salvi RJ. D-Methionine attenuates inner hair cell loss in carboplatin-treated chinchillas. Audiol Neurootol 2000;5:263-266.
14. Hofstetter P, Ding D, Powers N, Salvi RJ. Quantitative relationship of carboplatin dose to magnitude of inner and outer hair cell loss and the reduction in distortion product otoacoustic emission amplitude in chinchillas. Hear Res 1997;112:199-215.
15. Husain K, Scott RB, Whitworth C, Somani SM, Rybak LP. Dose response of carboplatin-induced hearing loss in rats: antioxidant defense system. Hear Res 2001;151:71-78.
16. Ekborn A, Laurell G, Andersson A, Wallin I, Eksborg S, Ehrsson H. Cisplatin-induced hearing loss: influence of the mode of drug administration in the guinea pig. Hear Res 2000;140:38-44.
17. Aruoma OI, Halliwell B, Hoey BM, Butler J. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 1989;6:593-597.
18. Kopke RD, Jackson RL, Coleman JK, Liu J, Bielefeld EC, Balough BJ. NAC for noise: from the bench top to the clinic. Hear Res 2007;226:114-125.
19. Coleman JK, Kopke RD, Liu J, et al. Pharmacological rescue of noise induced hearing loss using N-acetylcysteine and acetyl-L-carnitine. Hear Res 2007;226:104-113.
20. Dickey TD, Muldoon LL, Kraemer DF, Neuwelt EA. Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model. Hear Res 2004;193:25-30.
21. Bergamini S, Rota C, Canali R, et al. N-acetylcysteine inhibits in vivo nitric oxide production by inducible nitric oxide synthase. Nitric Oxide 2001;5:349-360.